Advertisement

Topics

Clearside Biomedical Announces Completion Of Patient Enrollment In Pivotal Phase III PEACHTREE Clinical Trial Of CLS-TA For Suprachoroidal Administration In Patients With Macular Edema Associated With Non-Infectious Uveitis

20:00 EDT 6 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Clearside Biomedical Announces Completion Of Patient Enrollment In Pivotal Phase III PEACHTREE Clinical Trial Of CLS-TA For Suprachoroidal Administration In Patients With Macular Edema Associated With Non-Infectious Uveitis

NEXT ARTICLE

More From BioPortfolio on "Clearside Biomedical Announces Completion Of Patient Enrollment In Pivotal Phase III PEACHTREE Clinical Trial Of CLS-TA For Suprachoroidal Administration In Patients With Macular Edema Associated With Non-Infectious Uveitis"

Quick Search
Advertisement